Health Innovation in Canada: Federal Role Roundtable
About the Health Innovation in Canada: Federal Role Roundtable
17 November 2014
The federal Ministry of Health (Health Canada) announced the creation of the Advisory Panel on Healthcare Innovation on June 24, 2014, to examine innovative health care ideas and approaches that exist in Canada and internationally. The Panel’s directive is to determine what approaches hold the greatest potential for Canadians and to create recommendations on how the Federal government can support those approaches.
On November 17th, 2014, the Institute of Health Economics (IHE) partnered with Eli Lilly Canada Inc. and the Canadian Institutes of Health Research’s Institute for Health Services and Policy Research to convene a meeting in Ottawa, Ontario of select thought leaders in health to help inform the Panel’s recommendations, and to provide policy makers and political representatives with recommendations on how to use innovation to meet the aforementioned goals.
Download Summary Report
Health Innovation in Canada: Federal Role Roundtable: Summary Report
The objectives for the roundtable were to:
- Discuss the current and potential use of federal levers to support healthcare innovation.
- Deliberate opportunities and barriers forthe federal government in engaging in the further development and application of healthcare innovation.
- Identify some directions and recommendations for the Advisory Panel on Healthcare Innovation’s consideration.